BioWave Medical
Advisory Board

Dr. Dominic A. Hegarty, MBBS, MSc, PhD

Former President World Institute of Pain Consultant in Pain Management & Neuromodulation, Mater Private Hospital Clinical Lead Neuromodulation Research, Tyndall National Institute, UCC Clinical Director Pain Relief Ireland

Dr. Alaa Abd-Elsayed, MD, MPH, FASA

Division Chief, Chronic Pain Medicine Dept. of Anesthesiology, Univ. of Wisconsin Medical Director, UW Health Pain Services Former Secretary, State Medical Board, Wisconsin

Dr. Raymond Tatevossian, MD

Founding Partner of Comprehensive Spine & Pain Physicians. Former Chairman of Pain and Palliative Care at Providence St. Joseph Medical Center

Dr. Phillip Kim MD

Founder & Director, Center for Interventional Pain and Spine. Member, American Academy of Pain Medicine, International Association for the Study of Pain, International Spine Injection Society, and North American Neuromodulation Society.

Dr. Amir Bahreman MD

Founder & Director, Neurological & Pain Institute. Quadruple board-certified neurologist with expertise in Neurology and Psychiatry, Brain Injury Medicine, Clinical Neurophysiology, and Vascular Neurology.

Dr. Charles A. Odonkor MD, MA

Assistant Professor, Yale University School of Medicine Dept of Orthopedics and Rehabilitation Interventional Pain Medicine and Physiatry Co-Director of Clinical Research

Bradford Siff

Founder & President
BioWave Corporation

Dr. Dominic Hegarty

BSc., BMedSc., MB., MSc. (Pain Management), PhD. FCARSCI, FFPMCAI, FIPP

Dr. Dominic Hegarty is a Consultant in Pain Management & Neuromodulation at the Mater Private Hospital, Cork, Senior Clinical Lecturer, and faculty member of ASSERT training at University College Cork where he promotes educational training in pain medicine.

At present he is the incoming President Elect of World Institute of Pain (WIP), Immediate past Honorary treasurer of WIP and on the Advisory Board of PainCast. In 2017 Dr. Hegarty hosted the WIP World congress in Dublin. He has gone on to be Clinical Lead of Neuromodulation Research, at Tyndall National Institute, UCC and has developed new device design.

Dr. Hegarty is a faculty member on several international organization including WIP, IASP and ERSA. He is an active researcher & has published extensively on pain management. He is an examiner on the FIPP fellowship exams. As a fellow at Guy’s & St. Thomas’ Hospital, London he developed his skills in neuromodulation and is presently an Honorary Consultant there.

Dr. Hegarty is the Clinical Director of Pain Relief Ireland (www.painreliefireland.ie) and the senior medial advisor to a number of med-tech companies who believes in providing multidisciplinary and interventional options for his patients in a timely fashion. He truly believes that neuromodulation offers great potential therapy options for certain individuals and we need to develop patient pathways to identify and manage these individuals.

  • President World Institute of Pain (WIP)
  • Consultant in Pain Management & Neuromodulation, Mater Private Hospital, Cork
  • Senior Clinical Lecturer, UCC
  • Honorary Consultant Guy’s & St. Thomas’ Hospital, London
  • Clinical Lead Neuromodulation Research, Tyndall National Institute, UCC
  • Clinical Director Pain Relief Ireland www.painreliefireland.ie

Dr. Raymond Tatevossian

MD

Dr. Raymond Tatevossian is a founding partner of Comprehensive Spine & Pain Physicians. He is a board certified anesthesiologist with fellowship training in Pain Medicine from the USC Keck School of Medicine.

Dr. Tatevossian has been practicing Pain Medicine for 15 years and has held the Chair of the Pain and Palliative Care at Providence St. Joseph Medical Center for the last 10 years. 

Dr. Tatevossian manages all chronic pain conditions. He holds special interest in minimally invasive spine procedures as well as the use of Regenerative medicine to alleviate chronic spine related pain conditions. He regularly lectures in the community as well as teaches new physicians advanced procedures. 

With membership in the American Academy of Pain Medicine as well as the American Society of Interventional Pain Physicians, Dr. Tatevossian is on the forefront of advanced treatment options in the field of Pain Medicine.

Dr. Charles Odonkor

MD, MA

Dr. Charles Odonkor is an assistant professor of Orthopedics and Rehabilitation, and Interventional Pain Medicine and Physiatry at Yale School of Medicine.

Dr. Odonkor completed a fellowship in pain medicine at Harvard Medical School and a physiatry residency and patient safety and health systems design fellowship at Johns Hopkins School of Medicine. As an alumnus of Yale School of Medicine, he was excited to return to Yale to bring his expertise in advanced pain intervention techniques, regenerative medicine and neuromodulation to alleviate chronic pain.

He is co-director of clinic research in the department of orthopaedics and rehabilitation and is PI of wearable health research at Yale.

Bradford Siff

M. Engr., MBA Founder & President

Brad is the founder of BioWave and a member of the Board of Directors. He is a skilled business leader and provides the guiding vision and strategic direction for the company. Brad manages new product and clinical development, quality, regulatory, contract manufacturing, government affairs and corporate finance. His original concept for BioWave’s signal technology came from an inspiration he had while working as the Chief Operating Officer at a prior medical device company. Brad also worked for 7 years as Senior Vice President of Mergers & Acquisitions for Daiwa Securities with a focus on the Medical Device Industry.

Brad received undergraduate and master’s degrees from Cornell Engineering and an MBA from Cornell’s Johnson Graduate School of Business. Brad’s Master of Engineering thesis was focused on a special project for the Hospital for Special Surgery. In his spare time, Brad is a fitness junkie and has been known to rip tremendous topspin on a tennis or paddle ball. He is an artist, photographer, and fond of traveling, skiing, food and wine.